Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Competition policy essential for access to medicines

28 January 2019

Medicines for Europe welcomes the publication of the European Commission […]

Read more

Crucial European Parliament vote vastly improves SPC manufacturing waiver

23 January 2019

Medicines for Europe welcomes today’s vote of the Legal Committee […]

Read more

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

Read more

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Read more

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Read more

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

The introduction of comprehensive SPC manufacturing waiver key to unlocking […]

Read more

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

The European Commission and OECD – Health at a Glance: […]

Read more

Value added medicines: Continuous innovation crucial to improve healthcare across Europe

21 November 2018

The 2nd Value Added Medicines conference gathered a wide range […]

Read more

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

Read more

US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver

22 October 2018

The US patent and trademark office (USPTO), together with the […]

Read more

Subscribe to our newsletter